当前位置:首页 - 行情中心 - 甘李药业(603087) - 财务分析 - 现金流量表

甘李药业

(603087)

  

流通市值:315.41亿  总市值:337.72亿
流通股本:5.58亿   总股本:5.97亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,090,250,158.473,782,135,444.222,799,253,112.311,844,216,752.72
  收到的税费返还2,386,431.9193,509,005.3485,506,119.0644,572,971.9
  收到其他与经营活动有关的现金7,832,632.42109,281,003.2775,818,636.5870,666,424.64
  经营活动现金流入小计1,100,469,222.83,984,925,452.832,960,577,867.951,959,456,149.26
  购买商品、接受劳务支付的现金232,102,273.63931,735,126.4725,969,731.03528,571,696.5
  支付给职工以及为职工支付的现金249,657,172.461,056,185,817.04764,768,091.94529,804,354.61
  支付的各项税费153,438,987.04249,605,277.71237,385,212.17187,711,333.93
  支付其他与经营活动有关的现金293,596,390.05963,123,964.32750,494,376.24464,818,522.13
  经营活动现金流出小计928,794,823.183,200,650,185.472,478,617,411.381,710,905,907.17
  经营活动产生的现金流量净额171,674,399.62784,275,267.36481,960,456.57248,550,242.09
二、投资活动产生的现金流量:
  收回投资收到的现金2,141,017,904.816,572,046,8704,862,623,9703,100,430,270
  取得投资收益收到的现金31,481,665.1592,611,984.3879,501,731.7555,644,592.68
  处置固定资产、无形资产和其他长期资产收回的现金净额-753,211.8118,05618,056
  处置子公司及其他营业单位收到的现金净额-309,616,697.13--
  收到的其他与投资活动有关的现金2,936,859.65---
  投资活动现金流入小计2,175,436,429.616,975,028,763.324,942,143,757.753,156,092,918.68
  购建固定资产、无形资产和其他长期资产支付的现金309,117,926.09926,089,327.81627,863,920.32366,970,304.43
  投资支付的现金2,120,968,4006,012,960,144.933,982,756,561.062,259,069,011.67
  投资活动现金流出小计2,430,086,326.096,939,049,472.744,610,620,481.382,626,039,316.1
  投资活动产生的现金流量净额-254,649,896.4835,979,290.58331,523,276.37530,053,602.58
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,000,000---
  筹资活动现金流入平衡项目0---
  筹资活动现金流入小计2,000,000---
  分配股利、利润或偿付利息支付的现金-597,525,269597,197,899597,525,269
  支付其他与筹资活动有关的现金241,788.6140,249,076.74140,071,249.6135,819,147.07
  筹资活动现金流出小计241,788.6737,774,345.74737,269,148.6733,344,416.07
  筹资活动产生的现金流量净额1,758,211.4-737,774,345.74-737,269,148.6-733,344,416.07
四、汇率变动对现金及现金等价物的影响-2,074,601.281,172,093.722,686,658.893,302,350.07
五、现金及现金等价物净增加额-83,291,886.7483,652,305.9278,901,243.2348,561,778.67
  加:期初现金及现金等价物余额343,530,556.97260,055,136.76260,055,136.76260,055,136.76
  期末现金及现金等价物余额260,238,670.23343,707,442.68338,956,379.99308,616,915.43
补充资料:
  净利润-1,143,583,603.28-603,680,572.48
  资产减值准备-36,125,457.82--18,215.12
  固定资产和投资性房地产折旧-287,261,585.84-132,680,148.88
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-287,261,585.84-132,680,148.88
  无形资产摊销-14,809,333.23-9,269,121.11
  长期待摊费用摊销-1,768,469.35-884,377.08
  处置固定资产、无形资产和其他长期资产的损失--3,712,360.69--
  固定资产报废损失-1,060,424.42-107,351.01
  公允价值变动损失--73,818,236.87--64,965,330.59
  财务费用--81,555,401.19--48,205,553.83
  投资损失--290,775,382.32--7,356,114.57
  递延所得税--53,308,217.73--20,390,658.37
  其中:递延所得税资产减少--60,497,518.65--13,330,978.7
    递延所得税负债增加-7,189,300.92--7,059,679.67
  存货的减少--28,868,123.06--121,169,652.02
  经营性应收项目的减少--364,475,894.21--506,000,735.9
  经营性应付项目的增加-106,221,072.41-229,370,078.69
  其他-73,589,075.8-38,824,093.87
  不涉及现金收支的投资和筹资活动金额其他项目-10,818,466.54-5,081,623.23
  现金的期末余额-343,707,442.68-308,616,915.43
  减:现金的期初余额-260,055,136.76-260,055,136.76
  现金及现金等价物的净增加额-83,652,305.92-48,561,778.67
公告日期2026-04-232026-04-232025-10-312025-08-08
审计意见(境内)标准无保留意见
TOP↑